clarity
beta
Data
Pricing
Support
Feedback
Log inSign up

Pages

Data
Pricing
Support
Feedback

Socials

Twitter
LinkedIn

Account

Log inSign up

clarity

ProductDataPricing
CompanyAboutSupportFeedback
LegalPrivacy PolicyTerms of Service
SocialTwitterLinkedIn
Copyright © 2026 Clarity Markets. All rights reserved.
United States

Gilead Sciences Inc

About

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

Key Statistics

Market Cap
158.56B
Price-Earnings ratio
18.84
Earnings-Per-Share
$6.78
52 Week Range
$92.83 - $156.40
Beta
0.40
Dividend Yield
2.42%

Analyst Ratings

74% Buy
of 31 ratings

Research Documents

Browse SEC filings and earnings transcripts.

AI Research
Analyze latest 10-K
View Financial Data
Start AI Chat
Recent News

Generate an AI-powered summary of the latest news and events for GILD.